WHO has published guidance on the public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This document combines and supersedes the Global surveillance guidance for COVID-19 caused by human infection with COVID-19 virus: Interim guidance, and Surveillance strategies for COVID-19 human infection: Interim Guidance 10 May 2020.
The Pan-American Health Organization/WHO Regional Office for the Americas/has drawn upon the Strategic Fund for Public Health Supplies to procure and distribute millions of COVID-19 diagnostic kits, Personal Protective Equipment (PPE), and other essential health supplies to countries throughout the region. Thus far, over 10 million PCR diagnostic tests have been sent to six countries. The Strategic Fund also helped finance PPE including face shields, gloves, goggles, gowns, masks and respirators for 26 countries in the region.
The WHO Regional Office for the Americas has issued a warning against the use of chlorine products as treatment for COVID-19. WHO recommends that people avoid consuming products containing chlorine dioxide or related substances (sodium hypochlorite, bleach, etc.) and that all marketing of such products for therapeutic purposes be reported to the authorities.